Talentmark are recruiting for a Senior Manager, International Training to join a global biotechnology company, on a contract basis for 12 months. This is a hybrid role with 2 days home working and 3 days based at site in Paddington.-
-
Company:
Our client is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases.
-
Salary:
From -473.85 per day PAYE to -600 per day UMB
-
-
Senior Manager, International Training Role:

• Lead training and capability initiatives for international field sales teams.
• Design and deliver launch training plans for new products and indications launches.
• Develop high-quality training materials, including learner content, workshops, and digital learning tools.
• Partner with Commercial, Marketing, Medical, Market Access, HR, and Compliance to ensure training is accurate, effective, and launch ready.
• Measure training effectiveness and continuously improve programs based on feedback and business needs.
• Support managers and field leaders with tools and resources that reinforce learning and enable sustained performance in the field.

-
Your Background:

• Hold a relevant degree or have equivalent working experience.
• Significant experience in commercial training, sales training, or capability development within biotech, pharmaceutical, or healthcare environments.
• Experience supporting field sales teams in speciality and/or rare disease markets.
• Proven experience developing and delivering launch training and field-facing learning materials.
• Strong understanding of specialty selling models and complex customer environments.
• Experience in international or global commercial organizations.
• -

-
Apply:
For more information, or to apply for this Senior Manager, International Training please contact the Key Accounts Team on (phone number removed) or email (url removed). Please quote reference (Apply online only).
-
It is essential that applicants hold entitlement to work in the UK
-
Please note:-This role may be subject to a satisfactory basic Disclosure and Barring Service (DBS) check.